Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Similarly, the R426A/R469A double mutant of c-MET cannot undergo autophosphorylation when stimulated with wild-type HGF (Fig
CagriSema: Awaiting a Critical FDA Decision Novo Nordisks CagriSema represents one of the most consequential pending decisions across the GLP-1 drug pipeline in 2026
localisez votre centre de rfrence
doi:10.1136/jcp.55.6.475
3 Biomedical Programme, School of Healthcare Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
US$ 20.79
US$ 23.88
US$ 20.25
